46 results about "Rubia" patented technology

An insecticide application to termites is obtained comprising at least one member selected from a plant, an extract of the plant, and an ooze (or exudate) of the plant, wherein the plant belongs to at least one genus selected from the group consisting of the genus Geranium, the genus Morus, the genus Artemisia, the genus Diospyros, the genus Crataegus, the genus Curcuma, the genus Rubia, the genus Polygonum, the genus Gardenia, the genus Cornus, the genus Uncaria, the genus Rheum, the genus Terminalia and the genus Saussurea. The extract may be a substance extracted with at least one member selected from the group consisting of water and a hydrophilic solvent. The insecticide exhibits high insecticidal and insect-controlling activity against insects (e.g., sanitarily injurious insects, insects injurious to houses and particularly to timber such as termites), being highly safe to human beings and animals and not adversely affecting the environment.

The present invention discloses compound pogonia japonica medicinal liquor for effectively curing the diseases of rheumatalgia, traumatic injuries, rheumatic arthritis, rheumatic gout, arthralgia due to wind-cold-dampness, lumbago due to pathogenic wind-dampness and others. It is made up by using Chinese medicinal materials of pogonia japonica, yiweiyao root, yeluma root, rubia maillardi, pachysandra axillaris and white liquor as raw material through a certain preparation process.

The invention discloses a traditional Chinese medicine composition as well as a preparation method, preparation and application thereof. The traditional Chinese medicine composition comprises 11-63 parts by weight of raw materials, 9-58 parts of Lobelia, 4-52 parts of Hedyotis diffusa, 13-76 parts of Dianchangshan leaves, 2-17 parts of Zijinlonggen 18~73 parts of Rubia root, 4~52 parts of Polygonum cuspidatum root, 19~75 parts of Imperata rhizome, 9~58 parts of Hatchling root, 11~63 parts of Gentiana and 5~57 parts of Prunella vulgaris, after pretreatment, extraction, Prepared by drying. The traditional Chinese medicine composition of the invention has the characteristics of multiple targets and multiple action channels, and has unique advantages in anti-cancer and anti-mutation. The traditional Chinese medicine composition of the invention has reasonable prescriptions, clear base sources of medicinal materials and clear application sites, scientific preparation method, clear and controllable quality indicators, high safety, remarkable curative effect, and broad application prospects.

The invention discloses a nutrient solution for removing heavy metal and drug residues in a chicken body and a preparation method thereof. The nutrient solution is characterized in that the active ingredients of the nutrient solution mainly comprise, by weight, 30-40 parts of dandelions, 20-25 parts of panax quinquefolius, 10-15 parts of lotus leaves, 5-10 parts of rubia membranacea, 5-10 parts oflemongrass herb, 2-5 parts of apricot kernels, 2-5 parts of radix codcnopsitis pilosulas, 1-3 parts of flos lonicerae and 1-3 parts of licorice roots. According to the nutrient solution, through a scientific proportion and a special preparation process, after fermentation of various traditional Chinese medicines, various natural compound active ingredients are generated, which can remove the heavy metal and drug residues in the chicken body, improve the chicken quality and improve the chicken taste, and the nutrient solution has the advantages of convenient use, a good use effect, no toxic orside effect, safety, stability and the like, and has good social and economic benefits.

The invention relates to the technical field of traditional Chinese medicines, and in particular relates to active ingredients of rubia cordifolia, a composition of the active ingredients, and applications of the composition. The invention provides the active ingredients of rubia cordifolia having the efficacies of purging heat and resisting inflammation. The composition of the active ingredients of rubia cordifolia is obtained through ethanol extraction, ethyl acetate extraction, and separation of the silicagel column. The invention further provides the applications of the medicinal composition with the efficacies of purging heat and resisting inflammation in preparing medicines for treating fever and inflammation. For the active ingredients of rubia cordifolia, and the composition provided by the invention, the components of the composition of the active ingredients of rubia cordifolia (with the efficacies of purging heat and resisting inflammation) have good synergetic functions of purging heat and resisting inflammation, therefore, the efficacies better that of the single component can be generated, and thus the active ingredients and the composition have good clinical medication development prospect.

A staltic Chinese medicine in the form of oral liquid for treating the abnormal metrorrhagia is prepared from 20 Chinese-medicinal materials including cuttlefish bone, madder, astragalus root, Chinese angelica root, etc. Its advantage is high curative effect.

The invention relates to a traditional Chinese medicine for treating breast hyperplasia and breast cancer. The traditional Chinese medicine can be used for effectively solving the treatment medicinal problems of the breast hyperplasia and breast cancer. The technical scheme for solving the problems is as follows: the traditional Chinese medicine is prepared from radix curcumae processed with vinegar, trigone processed with vinegar, rhizoma zedoariae processed with vinegar, processed pangolin, seaweed, iphigenia indica, radix codonopsitis, astragalus root, fruit of glossy privet, honeysuckle, lithospermum, chrysanthemum, rhizoma cyper processed with vinegar, trichosanthes, rubia root, corydalis tuber processed with vinegar, uniflower swisscentaury root, rhizoma coptidis, processed vomiting nut, chilopod, rheum officinale, fried cowherb seed, fried mustard seed, tangerine seed, prepared frankincense, prepared myrrh, oarweed and paris polyphylla. The material medicines are crushed and prepared into pills by using water and dried, respectively. The material medicines are effectively combined and supported with each other to achieve the effects of detoxicating and resolving a mass, tonifying qi and dredging collaterals, and promoting blood circulation to remove blood stasis. Besides, the traditional Chinese medicine is effectively used for treating the breast hyperplasia and breast cancer, and is safe in medicine use, good in curative effect and innovative on medicines for treating the breast hyperplasia and breast cancer.

The invention discloses effective fractions of rubia chinensis and its preparation method and application. The effective part of madder with high anthraquinone content is obtained by using the preparation method of the extract of the present invention, the preparation process is simple, and the organic solvent is fully extracted, so that the anthraquinone content in the effective part of madder is more than 40%, easy to operate, and low in cost . Experiments show that the effective parts of madder obtained by this method have a very good antiviral effect, and then it is further found through experiments that the higher the total anthraquinone content, the stronger the antiviral effect, showing that the anthraquinones of madder have stronger antiviral effects. active.

The invention discloses a rubiaceae type cyclic peptide diglucoside as well as its preparation method and application. The preparation method of the Rubiaceae type cyclic peptide diglycoside is as follows: using the stem and / leaf of the Rubiaceae Rubio genus Arthropodium as raw materials to obtain its extract, and the obtained extract is sequentially passed through a macroporous resin column, a silica gel column, a reversed-phase Silica gel column separation and purification, namely; when separated and purified by a macroporous resin column, the eluent is a mixed solvent composed of methanol or ethanol and water; when separated and purified by a silica gel column, the eluent is composed of chloroform and methanol mixed solvent; when separated and purified by a reverse-phase silica gel column, the eluent is a mixed solvent composed of methanol or acetonitrile and water. The applicant's experimental results show that the above-mentioned Rubiaceae type cyclic peptidoside has inhibitory activity of NF-κB signaling pathway and can be used as an inhibitor of NF-κB signaling pathway. The Rubiaceae type cyclic peptidoside has a structure shown in the following formula (I):